New app helps families break the silence on hereditary cancer

NCT ID NCT04214210

First seen May 20, 2026 · Last updated May 23, 2026 · Updated 1 time

Summary

This study tested a digital health platform designed to help people with a genetic mutation for hereditary breast and ovarian cancer communicate test results with their relatives. Researchers worked with 128 participants in Switzerland and Korea to see if the tool could reduce distress and increase the number of family members who learn about their own cancer risk. The goal was to improve family communication and encourage more at-risk relatives to get tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • HFR Fribourg - Hôpital cantonal

    Fribourg, Canton of Fribourg, 1752, Switzerland

  • Hirslanden Clinic Des Grangettes

    Geneva, Canton of Geneva, 1224, Switzerland

  • Hopital du Jura - Service d' Oncology

    Delémont, Canton of Jura, 2800, Switzerland

  • Istituto Oncologico della Zvizzera Italiana

    Bellinzona, 6962, Switzerland

  • Kantonalspital Winterthur

    Winterthur, Canton of Zurich, 8401, Switzerland

  • Unite d'Oncogenetique et de Prevention des Cancers

    Geneva, 1205, Switzerland

  • Universitatklinik fur Medizinische Onkologie, Inselspital

    Bern, 3010, Switzerland

  • University Hospital Basel

    Basel, 4056, Switzerland

Conditions

Explore the condition pages connected to this study.